On April 7, 2023, bathed in the warm spring, VACURE went through another year on the wheel of time and ushered in its 6th birthday.
The Founder of VACURE ,Dr.Tang,Ph.D. in Molecular Genetics, Shanghai Academy of Biological Sciences, Chinese Academy of Sciences,and part of Partners Dr.Pan,Dr.luo,Miss Wang cut the cake.
More than 200 employees and customers celebrated its 6th birthday today.
Who is VACURE?
Chengdu VACURE Biotechnology Co., Ltd. is a company focusing on the field of in vitro diagnostics (IVD) instant detection of POCT, specializing in the provision of in vitro diagnostic reagents and supporting equipment (POCT/molecular diagnosis/fluorescence immunity) products and integration of emergency and critical care (chest pain center/ Stroke Center/Trauma Center) and other national high-tech biotechnology enterprises that provide medical services, have their own R&D center with an area of 2,000 square meters, and a 100,000-level GMP purification production base with an area of ≥3,000 square meters.
Seek development by quality. VACURE attaches great importance to product quality. The R&D team has gathered experts from the Provincial Thousand Talents Program, and introduced many doctors from Peking University who are deeply involved in the in vitro diagnostic industry, as well as top technical experts who have been engaged in the IVD industry for more than ten years.
Driven by scientific and technological innovation. Based on the self-developed immunofluorescence quantitative detection platform LYOFIA system, VACURE iteratively upgrades the DISKFLU disc microfluidic immunological joint detection chip system, which can detect 9 items at the same time in 15 minutes, and the Genflu microfluidic molecular integrated POCT, with 25 inventions Patents, 17 utility model patents, 4 appearance patents, 8 trademark patents.
Accurate detection, keep pace with the times. With the development of its marketing in China and abroad, the company's products have successively passed the CE certification and ISO13485 quality management system certification. It has more than 30 NMPA registered products and more than 70 CE registered products. It is characterized by maternal and child products, and has achieved more than ten AMH, fFN, etc. Rapid detection of biological markers such as maternal and child products, cardiovascular and cerebrovascular, inflammation, growth and development, thyroid function, hormones, gastric function, tumor markers, etc. Application scenarios include laboratory departments of medical institutions at all levels, emergency rooms, health examination centers, community outpatient clinics, family personal health management, etc. It has established a product promotion and sales network covering more than 30 provinces, cities, and autonomous regions across the country, and gradually expanded Expand the layout of the international market, and the products are sold at home and abroad.
Adhering to the belief and mission of "helping the medical industry and caring for people's livelihood and health", VACURE will continue to provide high-quality products and services with ingenuity, and continue to provide high-quality products and services to contribute to the medical industry and forge ahead.